I am a healthcare professional in the UK
I am a patient or member of the publicResources
You are viewing Post-Transplant resources. Change therapy area preferences.
Explore a variety of curated resources by interacting with the filters below.
article
3 minutes
CMV is one of the most common infections experienced by transplant recipients
1 minute
article
5 minutes
Key efficacy outcomes from clinical trials evaluating LIVTENCITY in patients with post-transplant CMV, including virologic response and treatment comparisons.
download
1 minute
This concise guide to LIVTENCITY® (maribavir) is designed for clarity and ease of use. It summarises key insights from the Phase 3 SOLSTICE trial, including efficacy outcomes, safety data, and practical dosing guidance.
